Free. Unsubscribe any time.
Beam Therapeutics Inc. (BEAM)
Beam Therapeutics Inc. filed 32 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 6 reporting owners, covering 44 transactions and 474,690 shares. 32 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 9 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-07-29, came 27 days after the one before it (2026-07-02) and reports 1 transaction against 1 in the filing before it.
- The sales it reports total 16,667 shares, 16,294 more than the 373 in the filing before it.
- Its 32 plan statements rank 187th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 3 have more plan statements on file than it and 7 have fewer.
- Its 32 filings on file run from 2025-01-06 to 2026-07-29, and state 13 plan adoption dates, from 2023-02-27 to 2026-03-27.
Trades in Beam Therapeutics Inc. 44
- Bellon Christine — 2025-01-02 · S · 1,241 shares
- Cavanagh Bethany J — 2025-01-02 · S · 1,117 shares
- Evans John M. — 2025-01-30 · S · 29,800 shares
- Evans John M. — 2025-01-30 · S · 200 shares
- Bellon Christine — 2025-02-14 · S · 10,000 shares
- Cavanagh Bethany J — 2025-02-18 · S · 6,287 shares
- Bellon Christine — 2025-04-01 · S · 5,674 shares
- Cavanagh Bethany J — 2025-04-01 · S · 3,015 shares
- Ciaramella Giuseppe — 2025-04-01 · S · 7,434 shares
- Evans John M. — 2025-04-01 · S · 30,663 shares
- Simon Amy — 2025-04-01 · S · 9,566 shares
- Simon Amy — 2025-04-02 · S · 20,997 shares
Adoption dates in Beam Therapeutics Inc. 13
- 2023-02-27 — stated in 1 filing
- 2023-05-19 — stated in 11 filings
- 2023-05-23 — stated in 2 filings
- 2024-06-14 — stated in 2 filings
- 2024-08-09 — stated in 3 filings
- 2024-09-18 — stated in 1 filing
- 2024-09-20 — stated in 1 filing
- 2025-05-16 — stated in 4 filings
- 2025-08-11 — stated in 1 filing
- 2025-09-16 — stated in 2 filings
- 2025-09-19 — stated in 2 filings
- 2025-09-30 — stated in 1 filing
Results prints in Beam Therapeutics Inc. 9
- 2025-01-13
- 2025-02-25
- 2025-05-06
- 2025-08-05
- 2025-11-04
- 2026-01-12
- 2026-02-24
- 2026-05-07
- 2026-08-04
Trades before a print in Beam Therapeutics Inc. 1
- 0 days before the 2026-02-24 print — 2026-02-24 · S · Ciaramella Giuseppe · 35,000 shares
- 7 days before the 2025-02-25 print — 2025-02-18 · S · Cavanagh Bethany J · 6,287 shares
- 8 days before the 2026-08-04 print — 2026-07-27 · S · Simon Amy · 16,667 shares
- 11 days before the 2025-01-13 print — 2025-01-02 · S · Bellon Christine · 1,241 shares
- 11 days before the 2025-01-13 print — 2025-01-02 · S · Cavanagh Bethany J · 1,117 shares
- 11 days before the 2025-02-25 print — 2025-02-14 · S · Bellon Christine · 10,000 shares
- 12 days before the 2026-01-12 print — 2025-12-31 · S · Bellon Christine · 1,254 shares
- 12 days before the 2026-01-12 print — 2025-12-31 · S · Emany Sravan Kumar · 6,294 shares
- 25 days before the 2026-02-24 print — 2026-01-30 · S · Evans John M. · 22,094 shares
- 25 days before the 2026-02-24 print — 2026-01-30 · S · Evans John M. · 2,906 shares
- 26 days before the 2025-02-25 print — 2025-01-30 · S · Evans John M. · 29,800 shares
- 26 days before the 2025-02-25 print — 2025-01-30 · S · Evans John M. · 200 shares
Interval to Beam Therapeutics Inc.’s next reported results date
How the interval and sources are counted →
- 1within 5 days
- 3within 10 days
- 0shortest, days
- 0no later print
- Cavanagh Bethany J 2025-02-18 · S · 7 days before the 2025-02-25 print · SVP, Finance and Treasurer
- Ciaramella Giuseppe 2026-02-24 · S · 0 days before the 2026-02-24 print · President
- Simon Amy 2026-07-27 · S · 8 days before the 2026-08-04 print · Chief Medical Officer
Adoption dates Beam Therapeutics Inc. states
- 2023-02-27 in 1 filing
- 2023-05-19 in 11 filings
- 2023-05-23 in 2 filings
- 2024-06-14 in 2 filings
- 2024-08-09 in 3 filings
- 2024-09-18 in 1 filing
- 2024-09-20 in 1 filing
- 2025-05-16 in 4 filings
- 2025-08-11 in 1 filing
- 2025-09-16 in 2 filings
- 2025-09-19 in 2 filings
- 2025-09-30 in 1 filing
- 2026-03-27 in 1 filing
Filing text: “10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023”
Reported results dates on file
- 2025-01-13
- 2025-02-25
- 2025-05-06
- 2025-08-05
- 2025-11-04
- 2026-01-12
- 2026-02-24
- 2026-05-07
- 2026-08-04
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.